291 related articles for article (PubMed ID: 29526948)
1. Rituximab-induced Acute Thrombocytopenia in Granulomatosis with Polyangiitis.
Endo Y; Koga T; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Umeda M; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kawakami A
Intern Med; 2018 Aug; 57(15):2247-2250. PubMed ID: 29526948
[TBL] [Abstract][Full Text] [Related]
2. Intracranial granuloma in a patient with granulomatosis with polyangiitis under rituximab maintenance: A case report.
Ince B; Eroğlu E; Barburoğlu M; Yalçinkaya Y; Artim-Esen B; Gül A; Inanç M
Int J Rheum Dis; 2024 Jan; 27(1):e14887. PubMed ID: 37610040
[TBL] [Abstract][Full Text] [Related]
3. Blindness in a Sri Lankan woman with bilateral breast lumps: a case report.
Bataduwaarachchi VR; Galappaththi R; Tissera N
J Med Case Rep; 2015 Dec; 9():296. PubMed ID: 26714880
[TBL] [Abstract][Full Text] [Related]
4. [Recommendations on the use of rituximab for ANCA-associated vasculitis].
Gause AM; Rubbert-Roth A;
Z Rheumatol; 2014 Apr; 73(3):287-9. PubMed ID: 27039911
[TBL] [Abstract][Full Text] [Related]
5. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
[TBL] [Abstract][Full Text] [Related]
6. Late-onset neutropenia after rituximab in ANCA-associated vasculitis.
Knight A; Sundström Y; Börjesson O; Bruchfeld A; Malmström V; Gunnarsson I
Scand J Rheumatol; 2016 Oct; 45(5):404-7. PubMed ID: 26948245
[TBL] [Abstract][Full Text] [Related]
7. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
[TBL] [Abstract][Full Text] [Related]
8. Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan.
Alvarez L; Kambham N; Su R
J Nephrol; 2023 Nov; 36(8):2365-2370. PubMed ID: 37036661
[TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
[TBL] [Abstract][Full Text] [Related]
11. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
Timlin H; Lee SM; Manno RL; Seo P; Geetha D
Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
[TBL] [Abstract][Full Text] [Related]
12. Peripheral Ulcerative Keratitis Associated with Granulomatosis with Polyangiitis Emerging Despite Cyclophosphamide, Successfully Treated with Rituximab.
Fujita Y; Fukui S; Endo Y; Tsuji S; Takatani A; Shimizu T; Umeda M; Nishino A; Koga T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Ueki R; Uematsu M; Ishida K; Abe K; Kawakami A
Intern Med; 2018 Jun; 57(12):1783-1788. PubMed ID: 29321417
[TBL] [Abstract][Full Text] [Related]
13. B-cell-targeted therapy in systemic vasculitis.
Lally L; Spiera R
Curr Opin Rheumatol; 2016 Jan; 28(1):15-20. PubMed ID: 26599379
[TBL] [Abstract][Full Text] [Related]
14. Refractory antineutrophil cytoplasmic antibody-associated vasculitis successfully treated with rituximab: a case report.
Horai Y; Miyamura T; Takahama S; Hirata A; Nakamura M; Ando H; Minami R; Yamamoto M; Suematsu E
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(2):105-10. PubMed ID: 20453447
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis.
Teixeira V; Mohammad AJ; Jones RB; Smith R; Jayne D
RMD Open; 2019; 5(1):e000905. PubMed ID: 31245051
[TBL] [Abstract][Full Text] [Related]
16. Rituximab in ANCA-Associated Vasculitis.
Hassan RI; Gaffo AL
Curr Rheumatol Rep; 2017 Feb; 19(2):6. PubMed ID: 28155022
[TBL] [Abstract][Full Text] [Related]
17. Obinutuzumab as treatment for ANCA-associated vasculitis.
Amudala NA; Boukhlal S; Sheridan B; Langford CA; Geara A; Merkel PA; Cornec D
Rheumatology (Oxford); 2022 Aug; 61(9):3814-3817. PubMed ID: 34958343
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis.
Alberici F; Smith RM; Jones RB; Roberts DM; Willcocks LC; Chaudhry A; Smith KG; Jayne DR
Rheumatology (Oxford); 2015 Jul; 54(7):1153-60. PubMed ID: 25477054
[TBL] [Abstract][Full Text] [Related]
19. [Psoriatic arthritis during rituximab treatment of granulomatosis with polyangiitis: a new paradoxical side effect?].
Aussy A; Girszyn N; Vandhuick T; Marie I; Vittecoq O; Lévesque H; Benhamou Y
Rev Med Interne; 2015 Jul; 36(7):491-4. PubMed ID: 25554400
[TBL] [Abstract][Full Text] [Related]
20. Thrombocytopenia during avacopan administration: A case report.
Morimoto N; Mori T; Shioji S; Watanabe H; Sakai K; Mori K; Yamamura A; Hanioka A; Akagi Y; Fujiki T; Mandai S; Mori Y; Ando F; Susa K; Iimori S; Naito S; Sohara E; Uchida S
Int J Rheum Dis; 2023 Aug; 26(8):1603-1607. PubMed ID: 36880594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
